Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Tekla Life Sciences Investors Declares Distribution By: Tekla Life Sciences Investors via Business Wire February 15, 2023 at 10:33 AM EST On February 15, 2023, Tekla Life Sciences Investors declared a distribution of $0.33 per share. The record date for the distribution is February 27, 2023 and the payable date is March 31, 2023. The Fund will trade ex-distribution on February 24, 2023. Under its distribution policy, the Fund intends to make quarterly distributions at a rate of 2% of the Fund’s net assets. Therefore, when the net assets of the Fund are down, the distribution per share amount will decrease and when the net assets are up, the distribution amount per share will increase. This distribution will automatically be paid in newly issued shares of the Fund unless otherwise instructed by the shareholder. The shares will be valued at the lower of the net asset value or market price on the pricing date, March 23, 2023. Fractional shares will generally be settled in cash, except for registered shareholders with book entry accounts at the transfer agent who will have whole and fractional shares added to their account. Shareholders may request to be paid in cash instead of shares by responding to the bank, brokerage or nominee who holds the shares if the shares are in “street name” or by filling out an election card received from Computershare Investor Services shortly after the record date if the shares are in registered form. The bank, brokerage or nominee who holds the shares must advise the Depository Trust Company ("DTC") as to their full and fractional share requirements by March 22, 2023. Written notification for the election of cash instead of stock by registered shareholders must be received by Computershare Investor Services prior to March 22, 2023. Tekla Life Sciences Investors (NYSE: HQL) is a closed-end fund that invests in public and private companies in the life sciences industry. Tekla Capital Management LLC, based in Boston, serves as Investment Adviser to the Fund. Shares of the Fund can be purchased on the New York Stock Exchange through any securities broker. Information regarding the Fund and Tekla Capital Management LLC can be found at www.teklacap.com. Please contact Destra Capital Advisors, the Fund’s marketing and investor support services agent, at HQL@destracapital.com or call (877) 855-3434 if you have any questions regarding HQL. View source version on businesswire.com: https://www.businesswire.com/news/home/20230215005600/en/Contacts Destra Capital Advisors HQL@destracapital.com (877) 855-3434 Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Tekla Life Sciences Investors Declares Distribution By: Tekla Life Sciences Investors via Business Wire February 15, 2023 at 10:33 AM EST On February 15, 2023, Tekla Life Sciences Investors declared a distribution of $0.33 per share. The record date for the distribution is February 27, 2023 and the payable date is March 31, 2023. The Fund will trade ex-distribution on February 24, 2023. Under its distribution policy, the Fund intends to make quarterly distributions at a rate of 2% of the Fund’s net assets. Therefore, when the net assets of the Fund are down, the distribution per share amount will decrease and when the net assets are up, the distribution amount per share will increase. This distribution will automatically be paid in newly issued shares of the Fund unless otherwise instructed by the shareholder. The shares will be valued at the lower of the net asset value or market price on the pricing date, March 23, 2023. Fractional shares will generally be settled in cash, except for registered shareholders with book entry accounts at the transfer agent who will have whole and fractional shares added to their account. Shareholders may request to be paid in cash instead of shares by responding to the bank, brokerage or nominee who holds the shares if the shares are in “street name” or by filling out an election card received from Computershare Investor Services shortly after the record date if the shares are in registered form. The bank, brokerage or nominee who holds the shares must advise the Depository Trust Company ("DTC") as to their full and fractional share requirements by March 22, 2023. Written notification for the election of cash instead of stock by registered shareholders must be received by Computershare Investor Services prior to March 22, 2023. Tekla Life Sciences Investors (NYSE: HQL) is a closed-end fund that invests in public and private companies in the life sciences industry. Tekla Capital Management LLC, based in Boston, serves as Investment Adviser to the Fund. Shares of the Fund can be purchased on the New York Stock Exchange through any securities broker. Information regarding the Fund and Tekla Capital Management LLC can be found at www.teklacap.com. Please contact Destra Capital Advisors, the Fund’s marketing and investor support services agent, at HQL@destracapital.com or call (877) 855-3434 if you have any questions regarding HQL. View source version on businesswire.com: https://www.businesswire.com/news/home/20230215005600/en/Contacts Destra Capital Advisors HQL@destracapital.com (877) 855-3434
On February 15, 2023, Tekla Life Sciences Investors declared a distribution of $0.33 per share. The record date for the distribution is February 27, 2023 and the payable date is March 31, 2023. The Fund will trade ex-distribution on February 24, 2023. Under its distribution policy, the Fund intends to make quarterly distributions at a rate of 2% of the Fund’s net assets. Therefore, when the net assets of the Fund are down, the distribution per share amount will decrease and when the net assets are up, the distribution amount per share will increase. This distribution will automatically be paid in newly issued shares of the Fund unless otherwise instructed by the shareholder. The shares will be valued at the lower of the net asset value or market price on the pricing date, March 23, 2023. Fractional shares will generally be settled in cash, except for registered shareholders with book entry accounts at the transfer agent who will have whole and fractional shares added to their account. Shareholders may request to be paid in cash instead of shares by responding to the bank, brokerage or nominee who holds the shares if the shares are in “street name” or by filling out an election card received from Computershare Investor Services shortly after the record date if the shares are in registered form. The bank, brokerage or nominee who holds the shares must advise the Depository Trust Company ("DTC") as to their full and fractional share requirements by March 22, 2023. Written notification for the election of cash instead of stock by registered shareholders must be received by Computershare Investor Services prior to March 22, 2023. Tekla Life Sciences Investors (NYSE: HQL) is a closed-end fund that invests in public and private companies in the life sciences industry. Tekla Capital Management LLC, based in Boston, serves as Investment Adviser to the Fund. Shares of the Fund can be purchased on the New York Stock Exchange through any securities broker. Information regarding the Fund and Tekla Capital Management LLC can be found at www.teklacap.com. Please contact Destra Capital Advisors, the Fund’s marketing and investor support services agent, at HQL@destracapital.com or call (877) 855-3434 if you have any questions regarding HQL. View source version on businesswire.com: https://www.businesswire.com/news/home/20230215005600/en/
